EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease

Irene Simonetta iD, Irene Baglio, Antonino Tuttolomondo iD

Cells · 28.02.2026 · 15 (5) · 443

DOI: 10.3390/cells15050443 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.02.2026. Verfasst von Irene Simonetta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promoti…. Hauptthemen laut MEDLINE: Fabry Disease, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anderson–Fabry disease (FD) is an X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene, resulting in deficient α-galactosidase A activity and progressive accumulation of globotriaosylceramide (Gb3) and its derivative lyso-Gb3 within lysosomes. Beyond substrate storage, FD involves a complex interplay of molecular, metabolic, and inflammatory disturbances that collectively drive multisystemic damage. It seems that Gb3 accumulation impairs autophagic flux, promotes mitochondrial dysfunction, and triggers endoplasmic reticulum stress, leading to oxidative imbalance and bioenergetic failure. Concurrently, activation of innate immune pathways, particularly the TLR4/NF-κB axis, induces pro-inflammatory cytokine release and endothelial dysfunction, while complement activation and adaptive immune responses contribute to chronic inflammation and fibrosis. These mechanisms define a sustained state of “metaflammation,” linking lysosomal dysfunction to systemic inflammation. Understanding this molecular cross-talk provides a rationale for identifying novel biomarkers and designing therapies that go beyond enzymatic correction, including chaperone therapy, substrate reduction, and gene-based or anti-inflammatory approaches. A deeper comprehension of these interconnected patterns may guide the development of precision medicine strategies aimed at improving long-term outcomes in Fabry disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseInflammationHumansAnimalsTrihexosylceramidesLysosomesAutophagyalpha-GalactosidaseMitochondria

Stichwörter der Autor:innen

Fabry diseaseTLR4/NF-κB pathwaylysosomal dysfunctionmetabolic inflammationmitochondrial impairment

Substanzen

Trihexosylceramidesalpha-Galactosidaseglobotriaosylceramide

Autor:innen und Institutionen

  • Internal Medicine and Stroke Care Ward, Regional Reference Center for Diagnosis and Treatment of Anderson-Fabry Disease, Department of Health Promotion, Maternal and Child Health, Internal Medicine and Specialty Excelle…

ORCID-Profile: Irene Simonetta, Antonino Tuttolomondo

Zitieren

APA

Simonetta, I., Baglio, I., & Tuttolomondo, A. (2026). Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease. Cells, 15(5), 443. https://doi.org/10.3390/cells15050443

Vancouver

Simonetta I, Baglio I, Tuttolomondo A. Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease. Cells. 2026;15(5):443. doi:10.3390/cells15050443

BibTeX
@article{Simonetta2026,
  author = {Simonetta, Irene and Baglio, Irene and Tuttolomondo, Antonino},
  title = {Molecular, Metabolic and Inflammatory Patterns Involved in Pathogenesis of Anderson-Fabry Disease},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {443},
  doi = {10.3390/cells15050443}
}
Kostenlos starten →